Each year, the American Cancer Society invests $100 million in new research. But, because of the budget shortfall due to COVID-19, there is a risk of cutting cancer research funding by 50 percent this year. This would represent our lowest investment in this century.
We can’t let that happen. As the largest non-governmental funder of cancer research in the U.S., institutions and young investigators all over the country are counting on us. Patients, too.
Failing to invest in research now means that we will have fewer preventative tools, fewer treatment options, lost progress towards a cure, and ultimately, more deaths from cancer in the future.
Our outstanding track record is well known: 49 of the researchers we have funded, many early in their careers, have gone on to win the Nobel Prize. So, be proud when you talk to people about our research program. Let them know that cancer breakthrough begins perhaps 10-20 years earlier. If research is disrupted today, it means lives lost tomorrow.
Each of us can support this campaign. We urge all volunteers and staff to engage their personal networks in this campaign to help keep a generation of research alive.